Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 4-hydroxyphenyl retinamide | decreases expression | ISO | Cep57l1 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of CEP57L1 mRNA | CTD | PMID:28973697 | acetamide | increases expression | ISO | Cep57l1 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of CEP57L1 mRNA | CTD | PMID:31881176 | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of CEP57L1 intron | CTD | PMID:30157460 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CEP57L1 mRNA | CTD | PMID:23724009 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of CEP57L1 mRNA | CTD | PMID:33167477 | bisphenol A | decreases expression | ISO | Cep57l1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of CEP57L1 mRNA | CTD | PMID:26063408 | calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of CEP57L1 mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CEP57L1 mRNA | CTD | PMID:21592394 | chlorpyrifos | decreases expression | ISO | Cep57l1 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of CEP57L1 mRNA | CTD | PMID:37019170 | coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of CEP57L1 mRNA | CTD | PMID:19167446 | cyclosporin A | increases methylation | EXP | | 6480464 | Cyclosporine results in increased methylation of CEP57L1 promoter | CTD | PMID:27989131 | dibutyl phthalate | decreases expression | ISO | Cep57l1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of CEP57L1 mRNA | CTD | PMID:21266533 | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of CEP57L1 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CEP57L1 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of CEP57L1 mRNA | CTD | PMID:29803840 | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of CEP57L1 mRNA | CTD | PMID:23649840 | furan | increases expression | ISO | Cep57l1 (Rattus norvegicus) | 6480464 | furan results in increased expression of CEP57L1 mRNA | CTD | PMID:25539665 | gallic acid | decreases expression | EXP | | 6480464 | Gallic Acid results in decreased expression of CEP57L1 mRNA | CTD | PMID:34408198 | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of CEP57L1 mRNA | CTD | PMID:28988120 | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of CEP57L1 mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of CEP57L1 mRNA | CTD | PMID:28001369 | oxaliplatin | multiple interactions | ISO | Cep57l1 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CEP57L1 mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | Cep57l1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CEP57L1 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CEP57L1 mRNA | CTD | PMID:34911549 | paracetamol | increases expression | ISO | Cep57l1 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of CEP57L1 mRNA | CTD | PMID:33387578 | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of CEP57L1 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CEP57L1 mRNA | CTD | PMID:27188386 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CEP57L1 mRNA | CTD | PMID:27188386 | Soman | increases expression | ISO | Cep57l1 (Rattus norvegicus) | 6480464 | Soman results in increased expression of CEP57L1 mRNA | CTD | PMID:19281266 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of CEP57L1 mRNA | CTD | PMID:31533062 | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CEP57L1 mRNA | CTD | PMID:21592394 | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of CEP57L1 mRNA | CTD | PMID:21592394 | thioacetamide | increases expression | ISO | Cep57l1 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of CEP57L1 mRNA | CTD | PMID:23411599 | thioacetamide | affects expression | ISO | Cep57l1 (Rattus norvegicus) | 6480464 | Thioacetamide affects the expression of CEP57L1 mRNA | CTD | PMID:34492290 | titanium dioxide | increases expression | ISO | Cep57l1 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of CEP57L1 mRNA | CTD | PMID:29264374 | topotecan | multiple interactions | ISO | Cep57l1 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CEP57L1 mRNA | CTD | PMID:25729387 | triptonide | decreases expression | ISO | Cep57l1 (Mus musculus) | 6480464 | triptonide results in decreased expression of CEP57L1 mRNA | CTD | PMID:33045310 | trovafloxacin | decreases expression | ISO | Cep57l1 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of CEP57L1 mRNA | CTD | PMID:35537566 | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of CEP57L1 mRNA | CTD | PMID:28818685 | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of CEP57L1 gene | CTD | PMID:29154799 | vorinostat | increases expression | EXP | | 6480464 | vorinostat results in increased expression of CEP57L1 mRNA | CTD | PMID:27188386 | |